Naresh Tanna
Equibles does not estimate personal net worth.
Get an email with a short summary when Precision Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get DTIL alertsAbout Naresh Tanna
Naresh Tanna is recorded as CFO at Precision Biosciences Inc (DTIL) since August 1, 2026. Precision Biosciences Inc reported in an 8-K filed July 27, 2026 that Naresh Tanna was appointed Chief Financial Officer, effective August 1, 2026. Precision Biosciences Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precision Biosciences Inc includes Matthew Kane (CEO), Alex Kelly (COO and Chief Accounting Officer), Dario Scimeca (General Counsel) and 7 others.
“In connection with Mr. Kelly's promotion to Chief Operating Officer, the Board appointed Naresh Tanna, age 45, as Chief Financial Officer of the Company.”
Affiliation history
-
Current
2026-08-01–present
Company network
Leadership on record at Precision Biosciences Inc
- Matthew Kane CEO
- Alex Kelly COO, Chief Accounting Officer
- Dario Scimeca General Counsel
- Mei Burris Chief Accounting Officer
- Shane Barton Chief Accounting Officer
- Geno Germano Board Member
- Melinda Brown Board Member
- Michael Amoroso Board Member
- Samuel Wadsworth Board Member
- Samuel Wadsworth, Ph.D. Board Member